Phenylephrine tannate

Phenylephrine tannate, often combined with chlorpheniramine tannate, is designed to relieve upper respiratory symptoms by leveraging both decongestant and antihistamine effects. The tannate salt provides extended-release benefits, enabling dosing every 8–12 hours, though absorption remains comparable to other forms. It is grouped under the following drug class(es): Vasoconstrictors. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Rynatan and Metaoxedrine. Its PubChem CID is 165411843.

CAS No 1416-03-1
Molecular Formula C85H65NO48
Molecular Weight 1868.4 g/mol
Synonyms [2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate;3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol

Frequently Asked Questions